The Board of Directors, today approved the consolidated half-year financial report as at 30 June 2024. For the Group, it is a H1 24 of sustained growth:
- Revenues € 236 million (H1 23 restated : € 186 mln, +27%)
- EBITDA € 41 million (H1 23 restated: € 23 mln, +76%)
- EBITDA margin 17.2%(H1 23 restated: 12.4%)
- EBITDA Margin on adjusted revenue 18.3% (13.3% H1 23 restated)
- NFD: € 298 million (FY 23 restated: € 365 million), of which net debt to financial institutions amounting to € 235.4 million
- Proposed distribution of an extraordinary dividend as well as part of the Share Premium Reserve in the amount of EUR 0.35 per share
Fausto Manzana, CEO of the Gpi Group, remarked:
“In the first half of 2024 Gpi recorded significant growth in revenues and EBITDA, confirming the validity of its strategic path that is increasingly focused on software solutions for the transformation of healthcare globally. The markets in which we operate clearly show the need to structurally integrate digital technologies into healthcare models: we are ready to respond to this challenge with our technological solutions and artificial intelligence algorithms that are increasingly being applied in clinical practice.
The numbers in this half-yearly report are cause for great satisfaction, and, combined with the divestiture of Argentea, allow us to allocate part of the capital gain realised to an extraordinary dividend. This is the first time in our history as a listed company that we are distributing EUR 0.85 per share in a year, a tangible sign of our commitment to generate value for our shareholders.
In this context we are working on the definition of the new industrial plan, which will be based on innovation and the international growth of the Software SBA, thus guaranteeing the continuous evolution of the Group in line with the needs of the sector and the growth trends of Digital Health”.
